DK1444363T3 - Transfektions-kinitikker og strukturelle promotorer - Google Patents

Transfektions-kinitikker og strukturelle promotorer

Info

Publication number
DK1444363T3
DK1444363T3 DK02782194T DK02782194T DK1444363T3 DK 1444363 T3 DK1444363 T3 DK 1444363T3 DK 02782194 T DK02782194 T DK 02782194T DK 02782194 T DK02782194 T DK 02782194T DK 1444363 T3 DK1444363 T3 DK 1444363T3
Authority
DK
Denmark
Prior art keywords
structural promoters
kinetics
transfection
promoters
transfection kinetics
Prior art date
Application number
DK02782194T
Other languages
Danish (da)
English (en)
Inventor
Catherine J Pachuk
C Satishchandran
Original Assignee
Nucleonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucleonics Inc filed Critical Nucleonics Inc
Application granted granted Critical
Publication of DK1444363T3 publication Critical patent/DK1444363T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Lubricants (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK02782194T 2001-10-22 2002-10-22 Transfektions-kinitikker og strukturelle promotorer DK1444363T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34278801P 2001-10-22 2001-10-22
PCT/US2002/033669 WO2003035910A1 (en) 2001-10-22 2002-10-22 Transfection kinetics and structural promoters

Publications (1)

Publication Number Publication Date
DK1444363T3 true DK1444363T3 (da) 2007-01-29

Family

ID=23343276

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02782194T DK1444363T3 (da) 2001-10-22 2002-10-22 Transfektions-kinitikker og strukturelle promotorer

Country Status (7)

Country Link
EP (1) EP1444363B1 (de)
AT (1) ATE340271T1 (de)
AU (2) AU2002348372B2 (de)
CA (1) CA2464464A1 (de)
DE (1) DE60214877T2 (de)
DK (1) DK1444363T3 (de)
WO (1) WO2003035910A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897382B2 (en) 2001-10-22 2011-03-01 Alnylam Pharmaceuticals, Inc. Transfection kinetics and structural promoters
WO2004094654A2 (en) 2003-04-22 2004-11-04 Nucleonics, Inc. Transfection kinetics and structural promoters
TW200613554A (en) * 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
CA2824308A1 (en) 2004-09-24 2006-04-06 Alnylam Pharmaceuticals, Inc. Targeting opposite strand replication intermediates of single-stranded viruses by rnai

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9400522D0 (sv) * 1994-02-16 1994-02-16 Ulf Landegren Method and reagent for detecting specific nucleotide sequences
US5849727A (en) * 1996-06-28 1998-12-15 Board Of Regents Of The University Of Nebraska Compositions and methods for altering the biodistribution of biological agents

Also Published As

Publication number Publication date
EP1444363A4 (de) 2004-12-15
AU2002348372A2 (en) 2003-05-06
DE60214877T2 (de) 2007-02-15
WO2003035910A9 (en) 2004-12-23
CA2464464A1 (en) 2003-05-01
EP1444363A1 (de) 2004-08-11
AU2008249197A1 (en) 2008-12-18
DE60214877D1 (de) 2006-11-02
ATE340271T1 (de) 2006-10-15
AU2002348372B2 (en) 2008-08-28
AU2008249197B2 (en) 2012-01-19
WO2003035910A1 (en) 2003-05-01
EP1444363B1 (de) 2006-09-20

Similar Documents

Publication Publication Date Title
CY1119601T1 (el) Προαγωγεις αποπτωσης
ZA200603731B (en) Plasmid system for multiple expression
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
DE60037321D1 (de) Benzanilide als öffner des kaliumkanals
DK1601776T3 (da) Ekspressionsvektorer omfattende mCmV-IE2-promotoren
DE60124912D1 (de) Multimerische, einzelkettige, Tandem-Fv-Antikörper
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200716647A (en) Synthesis of (R)-N-methylnaltrexone
MXPA05014016A (es) Proteinas portadoras para vacunas.
BRPI0416141B8 (pt) anticorpo anti-cd52 modificado, composição farmacêutica, vetores de expressão, e método para preparar uma imunoglobulina
DK1847611T3 (da) Rhamnose-inducerbart ekspressionssystem
TW200604149A (en) Norbornane based cycloaliphatic compounds containing nitrile groups
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
CY1113789T1 (el) Συνδυασμοι απο ενεργοποιητες διαυλων καλιου και αναστολεις διαυλων νατριου ή δραστικες ουσιες που επηρεαζουν τους διαυλους νατριου για τη θεραπεια επωδυνων καταστασεων
EP1090294A4 (de) Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-gens und peptiden, die von ssx oder ny-eso-1 abgeleitet sind
ATE466079T1 (de) Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
BRPI0516576A (pt) vetores quiméricos
DK1444363T3 (da) Transfektions-kinitikker og strukturelle promotorer
ATE532861T1 (de) Expressionsvektor
SG142300A1 (en) Promoters for expression in modified vaccinia virus ankara
GB0324656D0 (en) A protein involved in ovarian cancer
WO2004094654A3 (en) Transfection kinetics and structural promoters
DK1480998T3 (da) Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
DK1664093T3 (da) Antitumorforbindelser baseret på kahalalid F
EP1183330A4 (de) Kv10.1, EIN NEUER POTENTIAL-ABHÄNGIGER KALIUMKANAL DES MENSCHLICHEN GEHIRNS